2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid

C32H52N2O5 — CID 131717552

IUPAC2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCC(=O)NCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C32H52N2O5/c1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-22-17-23(39-30(38)34-18-28(35)33-19-29(36)37)13-15-31(22,4)27(24)14-16-32(25,26)5/h9,20-21,23-27H,6-8,10-19H2,1-5H3,(H,33,35)(H,34,38)(H,36,37)/t21-,23+,24+,25-,26+,27+,31+,32-/m1/s1
InChIKeyLDBDCJWKKXYVPF-GTORSBDHSA-N
MW544.78 g/mol
LogP6.32
Rot. Bonds10

About 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid

2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid (PubChem CID 131717552) has the molecular formula C32H52N2O5 and a molecular weight of 544.78 g/mol. Its IUPAC name is 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid.

Molecular Properties

Compound Name2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid
PubChem CID131717552
Molecular FormulaC32H52N2O5
Molecular Weight544.78 g/mol
Exact Mass544.39
IUPAC Name2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid
SMILESCC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCC(=O)NCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C32H52N2O5/c1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-22-17-23(39-30(38)34-18-28(35)33-19-29(36)37)13-15-31(22,4)27(24)14-16-32(25,26)5/h9,20-21,23-27H,6-8,10-19H2,1-5H3,(H,33,35)(H,34,38)(H,36,37)/t21-,23+,24+,25-,26+,27+,31+,32-/m1/s1
InChIKeyLDBDCJWKKXYVPF-GTORSBDHSA-N
XLogP6.32
TPSA104.73 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds10
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500544.78
LogP ≤ 56.32
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid?
The IUPAC name of 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid (CID 131717552) is 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid.
What is the SMILES notation for 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid?
The canonical SMILES for 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid is CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)NCC(=O)NCC(=O)O)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid?
The InChIKey is LDBDCJWKKXYVPF-GTORSBDHSA-N. The full InChI is InChI=1S/C32H52N2O5/c1-20(2)7-6-8-21(3)25-11-12-26-24-10-9-22-17-23(39-30(38)34-18-28(35)33-19-29(36)37)13-15-31(22,4)27(24)14-16-32(25,26)5/h9,20-21,23-27H,6-8,10-19H2,1-5H3,(H,33,35)(H,34,38)(H,36,37)/t21-,23+,24+,25-,26+,27+,31+,32-/m1/s1.
What are the key properties of 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid?
2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid has a molecular weight of 544.78 g/mol, XLogP of 6.32, 10 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[2-[[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxycarbonylamino]acetyl]amino]acetic acid is sourced from PubChem (CID 131717552), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).